Article and Video CATEGORIES
Dr. Gelenis Domingo is a hematologist-oncologist at Memorial Cancer Institute.
She treats patients with a variety of cancers, including hematological malignancies (such as lymphoma and leukemia), blood benign hematology diseases, solid organ tumors (including breast, lung, prostate and colon cancer) and also cares for patients with anemia in pregnancy.
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community.
Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón, producida en español para nuestra comunidad latina, la Dra. Gelenis Domingo nos brinda información más actualizada. En este video, el Dr. Domingo analiza la terapia dirigida para NSCLC (ALK y ROs-1). Para unirse a la conversación, visite https://cancergrace.org/forum.
*****
For these additional videos to our Lung Cancer Video Library, produced in Spanish for our Latino Community, Dr. Gelenis Domingo provides us with more up to date information. In this video, Dr. Domingo discusses targeted therapy for NSCLC (ALK and ROs-1).
To join the conversation, visit https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…